Physician profile
Robert Bruce Bryan, II
NPI 1851466379
$4,071.60
in general payments reported to CMS, 2019-2025
10 companies · $1,130 in 2025
The $1,130 reported for 2025 was more than what 87% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $127 · 2020: $159 · 2021: $2,132 · 2022: $208 · 2024: $315 · 2025: $1,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $984 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $300 · Food and Beverage: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $983.59 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $300.00 |
| Food and Beverage | $161.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Henry Schein, INC. | $2,100.00 | 2021-2024 | |
| Stryker Corporation | $1,081.96 | 2025 | Patient-Fitted Tmj Reconstructive Prosthesis System, Na |
| Keystone Dental INC. | $332.28 | 2021 | |
| Carestream Dental, LLC | $192.72 | 2022 | |
| Neocis INC. | $159.09 | 2020 | |
| Straumann USA LLC | $78.27 | 2019 | |
| Nobel Biocare USA | $48.50 | 2019 | |
| Orapharma, A Division of Bausch Health US, LLC | $48.34 | 2025 | Arestin |
| Southern Implants North America INC | $15.68 | 2022 | |
| Zimvie INC. | $14.76 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Bryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.